Following three years of Medicaid’s continuous coverage requirements, Congress passed legislation terminating this provision. The resumption of Medicaid redeterminations has implications not only for the Medicaid program but also the individual market. Currently, there is limited data on the claims experience for those individuals who transitioned between Medicaid and the individual market in 2023, posing a challenge in understanding the full potential impacts. To delve deeper into possible effects, Wakely has performed a study utilizing individual market risk score experience to understand how Medicaid redetermination may affect the health of the individual market.
